Doctor Miyo Nakano

Prognosis of hypertrophic cardiomyopathy in Japanese patients with an implantable cardioverter defibrillator -focus on apical hypertrophic cardiomyopathy

Event: ESC Congress 2022

Topic: Hypertrophic Cardiomyopathy

Session: Arrhythmic risk stratification according to aetiology

Access

Like

Risk stratification for ischemic stroke and major bleeding in patients without atrial fibrillation -application of CHA2DS2-VASc and HAS-BLED scores-

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiogenic Embolism

Session: Stroke ePosters

Access

Like

Prognosis of apical hypertrophic cardiomyopathy in patients with an implantable cardioverter defibrillator

Event: ESC Congress 2021 - The Digital Experience

Topic: Hypertrophic Cardiomyopathy

Session: Congress committee e-posters choice in arrhythmias and device therapy

Access

Like

Impact of atrial fibrillation detected by implantable cardioverter-defibrillators on future stroke events in patients with heart failure

Event: ESC Congress 2019

Topic: Oral Anticoagulation

Session: Epidemiology of atrial fibrillation

Access

Like

Impact of subclinical atrial fibrillation detected by cardiac implantable electronic devices on the risk of future embolic stroke events from Far East

Event: ESC Congress 2019

Topic: Cardiogenic Embolism

Session: Heart and brain interaction - Stroke

Access

Like

Impact of stroke events in patients with atrial fibrillation detected by cardiac implantable electronic devices from Far East

Event: ESC Congress 2018

Topic: Cardiogenic Embolism

Session: Adverse kidney infections and other complications after coronary interventions

Access

Like

Prognosis of Japanese non-ischemic cardiomyopathy patients with an Implantable cardioverter-defibrillator for primary prophylaxis - cardiac sarcoidosis versus hypertrophic cardiomyopathy versus dilate

Event: ESC Congress 2018

Topic: Risk Factors and Risk Assessment

Session: Ventricular arrhythmias and SCD. Epidemiology, prognosis, outcome

Access

Like

Impact of stroke events in Japanese patients with atrial fibrillation detected by cardiac implantable electronic devices

Event: ESC Congress 2017

Topic: Stroke

Session: Interventions, peripheral circulation, stroke, surgery - Miscellaneous

Access

Like

Prognosis of cardiac sarcoidosis in patients with implantable cardioverter defibrillator -primary versus secondary prevention-

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Primary prevention (Sudden cardiac death and implantable defibrillators)

Session: Sudden cardiac death and implantable defibrillators

Access

Like

Risk classification for sudden cardiac death in japanese hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator in comparison between aha, jcs and esc guideline.

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Documents, Guidelines & Highlights

Session: Scientific documents and Guidelines

Access

Like

Doctor Miyo Nakano

Contributor content

Prognosis of hypertrophic cardiomyopathy in Japanese patients with an implantable cardioverter defibrillator -focus on apical hypertrophic cardiomyopathy

Risk stratification for ischemic stroke and major bleeding in patients without atrial fibrillation -application of CHA2DS2-VASc and HAS-BLED scores-

Prognosis of apical hypertrophic cardiomyopathy in patients with an implantable cardioverter defibrillator

Impact of atrial fibrillation detected by implantable cardioverter-defibrillators on future stroke events in patients with heart failure

Impact of subclinical atrial fibrillation detected by cardiac implantable electronic devices on the risk of future embolic stroke events from Far East

Impact of stroke events in patients with atrial fibrillation detected by cardiac implantable electronic devices from Far East

Prognosis of Japanese non-ischemic cardiomyopathy patients with an Implantable cardioverter-defibrillator for primary prophylaxis - cardiac sarcoidosis versus hypertrophic cardiomyopathy versus dilate

Impact of stroke events in Japanese patients with atrial fibrillation detected by cardiac implantable electronic devices

Prognosis of cardiac sarcoidosis in patients with implantable cardioverter defibrillator -primary versus secondary prevention-

Risk classification for sudden cardiac death in japanese hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator in comparison between aha, jcs and esc guideline.

ESC 365 is supported by

Doctor Miyo Nakano Follow

Contributor content

Prognosis of hypertrophic cardiomyopathy in Japanese patients with an implantable cardioverter defibrillator -focus on apical hypertrophic cardiomyopathy

Risk stratification for ischemic stroke and major bleeding in patients without atrial fibrillation -application of CHA2DS2-VASc and HAS-BLED scores-

Prognosis of apical hypertrophic cardiomyopathy in patients with an implantable cardioverter defibrillator

Impact of atrial fibrillation detected by implantable cardioverter-defibrillators on future stroke events in patients with heart failure

Impact of subclinical atrial fibrillation detected by cardiac implantable electronic devices on the risk of future embolic stroke events from Far East

Impact of stroke events in patients with atrial fibrillation detected by cardiac implantable electronic devices from Far East

Prognosis of Japanese non-ischemic cardiomyopathy patients with an Implantable cardioverter-defibrillator for primary prophylaxis - cardiac sarcoidosis versus hypertrophic cardiomyopathy versus dilate

Impact of stroke events in Japanese patients with atrial fibrillation detected by cardiac implantable electronic devices

Prognosis of cardiac sarcoidosis in patients with implantable cardioverter defibrillator -primary versus secondary prevention-

Risk classification for sudden cardiac death in japanese hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator in comparison between aha, jcs and esc guideline.

ESC 365 is supported by

Doctor Miyo Nakano